Compare ABEO & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | NFE |
|---|---|---|
| Founded | 1974 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 324.4M |
| IPO Year | 2005 | 2018 |
| Metric | ABEO | NFE |
|---|---|---|
| Price | $5.45 | $0.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $20.00 | $5.50 |
| AVG Volume (30 Days) | 1.0M | ★ 5.2M |
| Earning Date | 05-13-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,998,000.00 | ★ $1,504,037,000.00 |
| Revenue This Year | $1,024.31 | $110.34 |
| Revenue Next Year | $145.42 | $3.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $0.50 |
| 52 Week High | $7.54 | $4.96 |
| Indicator | ABEO | NFE |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 33.45 |
| Support Level | $5.20 | N/A |
| Resistance Level | $5.54 | $0.77 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 39.88 | 1.74 |
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.